Update on drugs for gastro-oesophageal reflux disease.
Keady
Simon
S
University College London Hospitals NHS Foundation Trust, London, UK. simon.keady@uclh.nhs.uk
D000293:Adolescent; D000863:Antacids / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D020117:Cisapride; D000075202:Contraindications; D004294:Domperidone / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D005764:Gastroesophageal Reflux / Q000178:diet therapy / Q000188:drug therapy* / Q000601:surgery; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007225:Infant Food; D007231:Infant, Newborn; D008787:Metoclopramide / Q000627:therapeutic use; D054328:Proton Pump Inhibitors
D000863:Antacids; D005765:Gastrointestinal Agents; D006633:Histamine Antagonists; D054328:Proton Pump Inhibitors; D004294:Domperidone; D004917:Erythromycin; D008787:Metoclopramide; D020117:Cisapride